https://pharmadog.xyz/news/395471 pharmadog en 2026-09-12T10:00:51.000Z Novartis encounters setbacks while AI firm Anthropic searches for a dealmaker https://pharmadog.xyz/news/395023 pharmadog en 2026-09-12T07:09:28.000Z AstraZeneca's breast cancer pill camizestrant fails to improve progression-free survival in pivotal SERENA-4 trial https://pharmadog.xyz/news/393831 pharmadog en 2026-09-11T23:30:21.000Z FDA approves Isembyld, first therapy to target muscle loss in SMA patients https://pharmadog.xyz/news/393586 pharmadog en 2026-09-11T22:17:19.000Z EU Advocate General backs pharma in fight over wastewater treatment cost https://pharmadog.xyz/news/393881 pharmadog en 2026-09-11T22:15:00.000Z Whole Foods recalls Cabricharme cheese after undisclosed egg protein found https://pharmadog.xyz/news/392551 pharmadog en 2026-09-11T16:35:51.000Z U.S. declares end to record cyclospora outbreak linked to iceberg lettuce https://pharmadog.xyz/news/392339 pharmadog en 2026-09-11T16:02:17.000Z FDA grants three-month review extension for Exelixis' metastatic colorectal cancer candidate https://pharmadog.xyz/news/392340 pharmadog en 2026-09-11T15:28:37.000Z Yarrow Bioscience raises $150M as AbbVie reports positive menstrual migraine trial results https://pharmadog.xyz/news/392341 pharmadog en 2026-09-11T15:22:09.000Z Trade group warns stalled biosimilar development could forfeit billions in savings https://pharmadog.xyz/news/392443 pharmadog en 2026-09-11T15:22:00.000Z RA Capital backs four biotech rounds in September as Novartis shares tumble after trial setbacks https://pharmadog.xyz/news/392275 pharmadog en 2026-09-11T15:13:06.000Z Alloy Therapeutics appoints Venkat Krishnamurthy as chief scientific officer of genetic medicines unit https://pharmadog.xyz/news/392276 pharmadog en 2026-09-11T15:10:36.000Z CMS guidance lets states use tier system to exempt medically frail Medicaid recipients from work requirements https://pharmadog.xyz/news/392231 pharmadog en 2026-09-11T15:01:59.000Z Alzheon seeks up to $500M in new financing after Phase 3 setback for Alzheimer’s drug https://pharmadog.xyz/news/392127 pharmadog en 2026-09-11T13:56:13.000Z Novartis investors grow wary as drug setbacks spark scrutiny of M&A strategy https://pharmadog.xyz/news/391999 pharmadog en 2026-09-11T13:39:52.000Z Cancer drug shortages persist, hampering patient care and highlighting lasting impacts of platinum chemotherapy https://pharmadog.xyz/news/392019 pharmadog en 2026-09-11T13:37:00.000Z Karyopharm Secures One-Month Debt Extension While Awaiting Xpovio Decision https://pharmadog.xyz/news/391979 pharmadog en 2026-09-11T13:22:30.000Z BioSpace to Host Webinar on Using Podcasts, Webinars and Thought Leadership for Pharma Marketing https://pharmadog.xyz/news/391980 pharmadog en 2026-09-11T13:19:28.000Z Samsung Biologics secures $262 million manufacturing contract with European pharma firm https://pharmadog.xyz/news/391871 pharmadog en 2026-09-11T12:30:13.000Z Disc sets up polycythemia vera challenge but Silence maintains lead https://pharmadog.xyz/news/391872 pharmadog en 2026-09-11T12:25:25.000Z Frazier Life Sciences raises over $1.1 billion for its small-mid-cap biotech fund, total commitments now $2.8 billion https://pharmadog.xyz/news/391783 pharmadog en 2026-09-11T11:55:00.000Z mRNA cancer vaccines’ biggest barriers to market https://pharmadog.xyz/news/391743 pharmadog en 2026-09-11T11:43:20.000Z Boycott Targeting American Diabetes Association Expands to Include Medical Journal https://pharmadog.xyz/news/391571 pharmadog en 2026-09-11T11:00:06.000Z Takeda R&D chief Andy Plump to retire in 2027 as Novo Nordisk names Alex Hoffman global research head https://pharmadog.xyz/news/391447 pharmadog en 2026-09-11T10:00:00.000Z Novartis shares tumble as three late-stage drug candidates fail trials https://pharmadog.xyz/news/391983 pharmadog en 2026-09-11T10:00:00.000Z Novartis shares tumble 13% after three late-stage drug setbacks hit market https://pharmadog.xyz/news/392206 pharmadog en 2026-09-11T09:55:00.000Z Revolution Medicines secures FDA approval for Rasonque, a RAS inhibitor targeting advanced pancreatic cancer https://pharmadog.xyz/news/392314 pharmadog en 2026-09-11T09:53:00.000Z FDA pushes back decision on Exelixis' zanzalintinib and Roche's Tecentriq combo for metastatic colorectal cancer https://pharmadog.xyz/news/391232 pharmadog en 2026-09-11T08:30:00.000Z Novartis and Novo Nordisk see back-to-back cardiovascular trial failures, raising doubts for the field https://pharmadog.xyz/news/391233 pharmadog en 2026-09-11T08:30:00.000Z Pro-vaccine advocates urged to add celebration to messaging after new safety data confirms flu, Covid-19 and RSV shots https://pharmadog.xyz/news/391234 pharmadog en 2026-09-11T08:30:00.000Z Thoracic surgeon warns that 9/11 exposure continues to cause lung cancer and mesothelioma decades later https://pharmadog.xyz/news/391231 pharmadog en 2026-09-11T08:30:00.000Z FDA grants de novo clearance to Powerful Medical’s AI tool for detecting severe heart attacks on EKGs https://pharmadog.xyz/news/390576 pharmadog en 2026-09-11T04:32:00.000Z FDA leadership stabilizes under new CBER and CDER heads and appoints first AI deputy commissioner https://pharmadog.xyz/news/390403 pharmadog en 2026-09-11T04:01:00.000Z Novartis board under fire as two late-stage trials fail and CAR-T program paused https://pharmadog.xyz/news/393616 pharmadog en 2026-09-11T00:00:00.000Z FDA plans study on barriers to women's enrollment in pregnancy exposure registries and announces PRV fee rates https://pharmadog.xyz/news/390994 pharmadog en 2026-09-10T23:39:00.000Z New FDA Oncology Center chief Angelo de Claro pledges AI integration and trial expansion